Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02023528 · ClinicalTrials.gov registry record

Dialysis Registry in Utah

A clinical trial, sponsored by University of Utah.

Completed
Registry status
243
Enrollment target

NCT02023528 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 243 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02023528 has completed, sponsored by University of Utah.

COMPLETED
Registry status
243 participants
Enrollment target

Study Summary

Based on the Medicare data, the 5-year survival of dialysis patients is only 39%. This is lower than that of stage IIIB breast cancer (54% 5-year survival). The annual mortality of dialysis patients is \~ 23% compared to \<0.1% in the United States general population. Even kidney transplant recipients have a substantially higher mortality (\~7%) compared to the general population. Consequently, the life-expectancy of dialysis and transplant populations is much lower than that of the general population. Cardiovascular events are the leading cause of death in dialysis patients and malnutrition is also a strong risk factor for death. The current proposal is to develop a prospective registry of incident dialysis patients at the University of Utah dialysis program to examine cardiovascular and nutritional factors in dialysis patients. This registry will include clinical and administrative data. In addition, blood samples will be stored for future analyses.

Trial Details

FieldValue
Enrollment Target 243 participants
Start Date 2008-01
Est. Completion 2015-12

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT02023528

The ClinicalTrials.gov registry entry for NCT02023528 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02023528 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02023528 about?

NCT02023528 is a clinical study titled "Dialysis Registry in Utah". Based on the Medicare data, the 5-year survival of dialysis patients is only 39%. This is lower than that of stage IIIB breast cancer (54% 5-year survival). The annual mortality of dialysis patients is \~ 23% compared to \<0.1% in the United States general population. Even kidney transplant recipien...

What is the current status of trial NCT02023528?

This trial is currently completed. The enrollment target is 243 participants. The study started on 2008-01. Estimated completion is 2015-12.

Who is sponsoring clinical trial NCT02023528?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.